KPTI vs UNP · rev $68.5M vs P/E 21, rev $6.86B
Karyopharm Therapeutics Inc (KPTI) versus Union Pacific Corporation (UNP) — a side-by-side from cached financials, not a winner call.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Union Pacific Corporation (UNP) is a railroads company listed on NYSE.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
Latest reported UNP revenue for 2026-06-30 was $6.86B. Net income was $1.99B. Revenue was up 10.4% from 2026-03-31 to 2026-06-30. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
KPTI currently screens at market cap $205.6M. UNP currently screens at market cap $153.21B and trailing P/E 21.3.
Not investment advice. Open the KPTI and UNP stock pages for the full models.
Not investment advice.